▶ 調査レポート

変形性股関節症鎮痛剤の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Hip Osteoarthritis Pain Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。変形性股関節症鎮痛剤の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Hip Osteoarthritis Pain Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-08107資料のイメージです。• レポートコード:D005-08107
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥372,360 (USD3,480)▷ お問い合わせ
  Multi User¥558,540 (USD5,220)▷ お問い合わせ
  Corporate User¥744,720 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、変形性股関節症鎮痛剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。変形性股関節症鎮痛剤の種類別市場規模(経口、注射、外用)、用途別市場規模(医療、パーソナルケア)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、Horizon Pharma、Bayer、Johnson and Johnson、Sanofi、GlaxoSmithKline、Mylan、Novartis、Eli Lilly、Abbott、Tide Pharmaceutical、Abiogen Pharma、Daiichi Sankyo、Iroko Pharmaceuticals、Astellas Pharma、TEVA、Hengrui Pharmaceutical、Almatica Pharma
・地域別グローバル市場分析 2015年-2020年
・変形性股関節症鎮痛剤の北米市場(アメリカ、カナダ、メキシコ)
・変形性股関節症鎮痛剤のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・変形性股関節症鎮痛剤のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・変形性股関節症鎮痛剤の南米市場(ブラジル、アルゼンチン)
・変形性股関節症鎮痛剤の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:経口、注射、外用
・用途別分析:医療、パーソナルケア
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Hip Osteoarthritis Pain Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Hip Osteoarthritis Pain Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Hip Osteoarthritis Pain Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Hip Osteoarthritis Pain Drug market has been segmented into
Oral
Injection
External

By Application, Hip Osteoarthritis Pain Drug has been segmented into:
Medical Care
Personal Care

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hip Osteoarthritis Pain Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Hip Osteoarthritis Pain Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hip Osteoarthritis Pain Drug market.

The report offers in-depth assessment of the growth and other aspects of the Hip Osteoarthritis Pain Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Hip Osteoarthritis Pain Drug Market Share Analysis
Hip Osteoarthritis Pain Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hip Osteoarthritis Pain Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hip Osteoarthritis Pain Drug sales, revenue and market share for each player covered in this report.

The major players covered in Hip Osteoarthritis Pain Drug are:
Pfizer
Horizon Pharma
Bayer
Johnson and Johnson
Sanofi
GlaxoSmithKline
Mylan
Novartis
Eli Lilly
Abbott
Tide Pharmaceutical
Abiogen Pharma
Daiichi Sankyo
Iroko Pharmaceuticals
Astellas Pharma
TEVA
Hengrui Pharmaceutical
Almatica Pharma

Among other players domestic and global, Hip Osteoarthritis Pain Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hip Osteoarthritis Pain Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hip Osteoarthritis Pain Drug, with price, sales, revenue and global market share of Hip Osteoarthritis Pain Drug in 2018 and 2019.
Chapter 3, the Hip Osteoarthritis Pain Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hip Osteoarthritis Pain Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Hip Osteoarthritis Pain Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Hip Osteoarthritis Pain Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Hip Osteoarthritis Pain Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hip Osteoarthritis Pain Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market Analysis by Application
1.3.1 Overview: Global Hip Osteoarthritis Pain Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Overview of Global Hip Osteoarthritis Pain Drug Market
1.4.1 Global Hip Osteoarthritis Pain Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Horizon Pharma
2.2.1 Horizon Pharma Details
2.2.2 Horizon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Horizon Pharma SWOT Analysis
2.2.4 Horizon Pharma Product and Services
2.2.5 Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson and Johnson
2.4.1 Johnson and Johnson Details
2.4.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson and Johnson SWOT Analysis
2.4.4 Johnson and Johnson Product and Services
2.4.5 Johnson and Johnson Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eli Lilly SWOT Analysis
2.9.4 Eli Lilly Product and Services
2.9.5 Eli Lilly Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Abbott SWOT Analysis
2.10.4 Abbott Product and Services
2.10.5 Abbott Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Tide Pharmaceutical
2.11.1 Tide Pharmaceutical Details
2.11.2 Tide Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Tide Pharmaceutical SWOT Analysis
2.11.4 Tide Pharmaceutical Product and Services
2.11.5 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Abiogen Pharma
2.12.1 Abiogen Pharma Details
2.12.2 Abiogen Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Abiogen Pharma SWOT Analysis
2.12.4 Abiogen Pharma Product and Services
2.12.5 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Daiichi Sankyo
2.13.1 Daiichi Sankyo Details
2.13.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Daiichi Sankyo SWOT Analysis
2.13.4 Daiichi Sankyo Product and Services
2.13.5 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Iroko Pharmaceuticals
2.14.1 Iroko Pharmaceuticals Details
2.14.2 Iroko Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Iroko Pharmaceuticals SWOT Analysis
2.14.4 Iroko Pharmaceuticals Product and Services
2.14.5 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Astellas Pharma
2.15.1 Astellas Pharma Details
2.15.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Astellas Pharma SWOT Analysis
2.15.4 Astellas Pharma Product and Services
2.15.5 Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 TEVA
2.16.1 TEVA Details
2.16.2 TEVA Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 TEVA SWOT Analysis
2.16.4 TEVA Product and Services
2.16.5 TEVA Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hengrui Pharmaceutical
2.17.1 Hengrui Pharmaceutical Details
2.17.2 Hengrui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Hengrui Pharmaceutical SWOT Analysis
2.17.4 Hengrui Pharmaceutical Product and Services
2.17.5 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Almatica Pharma
2.18.1 Almatica Pharma Details
2.18.2 Almatica Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Almatica Pharma SWOT Analysis
2.18.4 Almatica Pharma Product and Services
2.18.5 Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Hip Osteoarthritis Pain Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Hip Osteoarthritis Pain Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Hip Osteoarthritis Pain Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Hip Osteoarthritis Pain Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Hip Osteoarthritis Pain Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Hip Osteoarthritis Pain Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
4.3 Europe Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
4.5 South America Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country
5.1.1 North America Hip Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Hip Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
5.3 Canada Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Hip Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Hip Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
6.3 UK Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
6.4 France Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
6.5 Russia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
6.6 Italy Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Hip Osteoarthritis Pain Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
7.3 Japan Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
7.4 Korea Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
7.5 India Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
7.7 Australia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country
8.1.1 South America Hip Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Hip Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Hip Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Hip Osteoarthritis Pain Drug Sales and Market Share by Type (2015-2020)
10.2 Global Hip Osteoarthritis Pain Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Hip Osteoarthritis Pain Drug Price by Type (2015-2020)
11 Global Hip Osteoarthritis Pain Drug Market Segment by Application
11.1 Global Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
11.2 Global Hip Osteoarthritis Pain Drug Revenue Market Share by Application (2015-2020)
11.3 Global Hip Osteoarthritis Pain Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Hip Osteoarthritis Pain Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Hip Osteoarthritis Pain Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)
12.2.2 Europe Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)
12.2.4 South America Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)
12.3 Hip Osteoarthritis Pain Drug Market Forecast by Type (2021-2025)
12.3.1 Global Hip Osteoarthritis Pain Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Hip Osteoarthritis Pain Drug Market Share Forecast by Type (2021-2025)
12.4 Hip Osteoarthritis Pain Drug Market Forecast by Application (2021-2025)
12.4.1 Global Hip Osteoarthritis Pain Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Hip Osteoarthritis Pain Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Hip Osteoarthritis Pain Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hip Osteoarthritis Pain Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hip Osteoarthritis Pain Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Hip Osteoarthritis Pain Drug Major Business
Table 9. Pfizer Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Hip Osteoarthritis Pain Drug Product and Services
Table 12. Pfizer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Horizon Pharma Hip Osteoarthritis Pain Drug Major Business
Table 15. Horizon Pharma Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 16. Horizon Pharma SWOT Analysis
Table 17. Horizon Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 18. Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Hip Osteoarthritis Pain Drug Major Business
Table 21. Bayer Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 22. Bayer SWOT Analysis
Table 23. Bayer Hip Osteoarthritis Pain Drug Product and Services
Table 24. Bayer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson and Johnson Hip Osteoarthritis Pain Drug Major Business
Table 27. Johnson and Johnson Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 28. Johnson and Johnson SWOT Analysis
Table 29. Johnson and Johnson Hip Osteoarthritis Pain Drug Product and Services
Table 30. Johnson and Johnson Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Hip Osteoarthritis Pain Drug Major Business
Table 33. Sanofi Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi Hip Osteoarthritis Pain Drug Product and Services
Table 36. Sanofi Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 38. GlaxoSmithKline Hip Osteoarthritis Pain Drug Major Business
Table 39. GlaxoSmithKline Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 40. GlaxoSmithKline SWOT Analysis
Table 41. GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Services
Table 42. GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Hip Osteoarthritis Pain Drug Major Business
Table 45. Mylan Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 46. Mylan SWOT Analysis
Table 47. Mylan Hip Osteoarthritis Pain Drug Product and Services
Table 48. Mylan Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis Basic Information, Manufacturing Base and Competitors
Table 50. Novartis Hip Osteoarthritis Pain Drug Major Business
Table 51. Novartis Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 52. Novartis SWOT Analysis
Table 53. Novartis Hip Osteoarthritis Pain Drug Product and Services
Table 54. Novartis Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 56. Eli Lilly Hip Osteoarthritis Pain Drug Major Business
Table 57. Eli Lilly Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 58. Eli Lilly SWOT Analysis
Table 59. Eli Lilly Hip Osteoarthritis Pain Drug Product and Services
Table 60. Eli Lilly Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Abbott Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Hip Osteoarthritis Pain Drug Major Business
Table 63. Abbott Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 64. Abbott SWOT Analysis
Table 65. Abbott Hip Osteoarthritis Pain Drug Product and Services
Table 66. Abbott Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Major Business
Table 69. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 70. Tide Pharmaceutical SWOT Analysis
Table 71. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
Table 72. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Abiogen Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Abiogen Pharma Hip Osteoarthritis Pain Drug Major Business
Table 75. Abiogen Pharma Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 76. Abiogen Pharma SWOT Analysis
Table 77. Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 78. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 80. Daiichi Sankyo Hip Osteoarthritis Pain Drug Major Business
Table 81. Daiichi Sankyo Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 82. Daiichi Sankyo SWOT Analysis
Table 83. Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Services
Table 84. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Major Business
Table 87. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 88. Iroko Pharmaceuticals SWOT Analysis
Table 89. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Services
Table 90. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Hip Osteoarthritis Pain Drug Major Business
Table 93. Astellas Pharma Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 94. Astellas Pharma SWOT Analysis
Table 95. Astellas Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 96. Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. TEVA Basic Information, Manufacturing Base and Competitors
Table 98. TEVA Hip Osteoarthritis Pain Drug Major Business
Table 99. TEVA Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 100. TEVA SWOT Analysis
Table 101. TEVA Hip Osteoarthritis Pain Drug Product and Services
Table 102. TEVA Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Major Business
Table 105. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 106. Hengrui Pharmaceutical SWOT Analysis
Table 107. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
Table 108. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Almatica Pharma Hip Osteoarthritis Pain Drug Type and Application
Table 110. Almatica Pharma Hip Osteoarthritis Pain Drug Major Business
Table 111. Almatica Pharma Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)
Table 112. Almatica Pharma SWOT Analysis
Table 113. Almatica Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 114. Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Hip Osteoarthritis Pain Drug Sales by Manufacturer (2018-2019) (K Units)
Table 116. Global Hip Osteoarthritis Pain Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Hip Osteoarthritis Pain Drug Sales by Regions (2015-2020) (K Units)
Table 118. Global Hip Osteoarthritis Pain Drug Sales Market Share by Regions (2015-2020)
Table 119. Global Hip Osteoarthritis Pain Drug Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Hip Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)
Table 121. North America Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)
Table 122. North America Hip Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)
Table 124. Europe Hip Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)
Table 125. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)
Table 126. Europe Hip Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Regions (2015-2020) (K Units)
Table 128. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Hip Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)
Table 131. South America Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)
Table 132. South America Hip Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)
Table 135. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)
Table 138. Global Hip Osteoarthritis Pain Drug Sales by Type (2015-2020) (K Units)
Table 139. Global Hip Osteoarthritis Pain Drug Sales Share by Type (2015-2020)
Table 140. Global Hip Osteoarthritis Pain Drug Revenue by Type (2015-2020) (USD Million)
Table 141. Global Hip Osteoarthritis Pain Drug Revenue Share by Type (2015-2020)
Table 142. Global Hip Osteoarthritis Pain Drug Sales by Application (2015-2020) (K Units)
Table 143. Global Hip Osteoarthritis Pain Drug Sales Share by Application (2015-2020)
Table 144. Global Hip Osteoarthritis Pain Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 145. Global Hip Osteoarthritis Pain Drug Market Share Forecast by Regions (2021-2025)
Table 146. Global Hip Osteoarthritis Pain Drug Sales Forecast by Type (2021-2025) (K Units)
Table 147. Global Hip Osteoarthritis Pain Drug Market Share Forecast by Type (2021-2025)
Table 148. Global Hip Osteoarthritis Pain Drug Sales Forecast by Application (2021-2025)
Table 149. Global Hip Osteoarthritis Pain Drug Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Hip Osteoarthritis Pain Drug Picture
Figure 2. Global Sales Market Share of Hip Osteoarthritis Pain Drug by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. External Picture
Figure 6. Hip Osteoarthritis Pain Drug Sales Market Share by Application in 2018
Figure 7. Medical Care Picture
Figure 8. Personal Care Picture
Figure 9. Global Hip Osteoarthritis Pain Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Hip Osteoarthritis Pain Drug Sales Market Share by Manufacturer in 2019
Figure 30. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Hip Osteoarthritis Pain Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Hip Osteoarthritis Pain Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Regions (2015-2020)
Figure 37. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Regions in 2018
Figure 38. North America Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
Figure 39. Europe Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
Figure 41. South America Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)
Figure 43. North America Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)
Figure 45. North America Hip Osteoarthritis Pain Drug Sales Market Share by Countries in 2018
Figure 46. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries in 2018
Figure 48. United States Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Countries in 2019
Figure 54. Germany Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue Market Share by Regions 2019
Figure 62. China Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Hip Osteoarthritis Pain Drug Sales Market Share by Countries in 2019
Figure 69. South America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries in 2019
Figure 70. Brazil Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Hip Osteoarthritis Pain Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel